medigraphic.com
ISSN 2992-8036 (Digital)
ISSN 2306-4102 (Impreso)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2013, Número S1

<< Anterior Siguiente >>

Acta Ortop Mex 2013; 27 (S1)


Selección de prótesis

Idioma: Español
Referencias bibliográficas: 70
Paginas: 91-98
Archivo PDF: 178.34 Kb.


FRAGMENTO

Pregunta 1: ¿Influye el tipo de prótesis en la incidencia de infección en el sitio quirúrgico (ISQx) o en la infección en la articulación periprotésica (IAP)?

Consenso: El tipo de prótesis (cementada o no cementada) o con recubrimiento de hidroxiapatita no influye en la incidencia de ISQx o IAP.
Votación de los delegados: De acuerdo, 92%, en desacuerdo, 4%. Abstenciones, 4%. (Consenso fuerte.)


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Corten K, Bourne RB, Charron KD, Au K, Rorabeck CH: What works best, a cemented or cementless primary total hip arthroplasty?: minimum 17-year follow up of a randomized controlled trial. Clin Orthop Relat Res. 2011; 469(1): 209-217.

  2. Morshed S, Bozic KJ, Ries MD, Malchau H, Colford JM Jr: Comparison of cemented and uncemented fixation in total hip replacement: a meta-analysis. Acta Orthop. 2007; 78(3): 315-326.

  3. Hailer NP, Garellick G, Karrholm J: Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register. Acta Orthop. 2010; 81(1): 34-41.

  4. Dale H, Hallan G, Espehaug B, Havelin LI, Engesaeter LB: Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop. 2009; 80(6): 639-645.

  5. Engesaeter LB, Espehaug B, Lie SA, Furnes O, Havelin LI: Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register. Acta Orthop. 2006; 77(3): 351-358.

  6. Dale H, Skramm I, Lower HL, et al: Infection after primary hip arthroplasty: a comparison of 3 Norwegian health registers. Acta Orthop. 2011; 82(6): 646-654.

  7. Dale H, Fenstad AM, Hallan G, et al: Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop. 2011; 83(5): 449-458.

  8. Parker MJ, Gurusamy KS, Azegami S: Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev. 2010(6): CD001706.

  9. Taylor F, Wright M, Zhu M: Hemiarthroplasty of the hip with and without cement: a randomized clinical trial. J Bone Joint Surg Am. 2012; 94(7): 577-583.

  10. Kim YH, Kim JS, Park JW, Joo JH: Contemporary total hip arthroplasty with and without cement in patients with osteonecrosis of the femoral head: a concise follow-up, at an average of seventeen years, of a previous report. J Bone Joint Surg Am. 2011; 93(19): 1806-1810.

  11. Weiss RJ, Stark A, Karrholm J: A modular cementless stem vs. cemented long-stem prostheses in revision surgery of the hip: a population-based study from the Swedish Hip Arthroplasty Register. Acta Orthop. 2011; 82(2): 136-142.

  12. Nakama GY, Peccin MS, Almeida GJ, Lira Neto Ode A, Queiroz AA, Navarro RD: Cemented, cementless or hybrid fixation options in total knee arthroplasty for osteoarthritis and other non-traumatic diseases. Cochrane Database Syst Rev. 2012; 10: CD006193.

  13. Park JW, Kim YH. Simultaneous cemented and cementless total knee replacement in the same patients: a prospective comparison of long-term outcomes using an identical design of NexGen prosthesis. J Bone Joint Surg Br. 2011; 93(11): 1479-1486.

  14. Khaw FM, Kirk LM, Morris RW, Gregg PJ: A randomised, controlled trial of cemented versus cementless press-fit condylar total knee replacement. Ten-year survival analysis. J Bone Joint Surg Br. 2002; 84(5): 658-666.

  15. Baker PN, Khaw FM, Kirk LM, Esler CN, Gregg PJ: A randomised controlled trial of cemented versus cementless press-fit condylar total knee replacement: 15-year survival analysis. J Bone Joint Surg Br. 2007; 89(12): 1608-1614.

  16. Beaupre LA, al-Yamani M, Huckell JR, Johnston DW: Hydroxyapatite-coated tibial implants compared with cemented tibial fixation in primary total knee arthroplasty. A randomized trial of outcomes at five years. J Bone Joint Surg Am. 2007; 89(10): 2204-2211.

  17. Nilsson KG, Karrholm J, Carlsson L, Dalen T: Hydroxyapatite coating versus cemented fixation of the tibial component in total knee arthroplasty: prospective randomized comparison of hydroxyapatite-coated and cemented tibial components with 5-year follow-up using radiostereometry. J Arthroplasty. 1999; 14(1): 9-20.

  18. Chiu FY, Chen CM, Lin CF, Lo WH: Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am. 2002; 84-A(5): 759-762.

  19. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY: Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomised study. J Bone Joint Surg Br. 2001; 83(5): 691-695.

  20. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N: Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br. 1997; 79(4): 590-595.

  21. Parvizi J, Saleh KJ, Ragland PS, Pour AE, Mont MA: Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop. 2008; 79(3): 335-341.

  22. Chiu FY, Lin CF: Antibiotic-impregnated cement in revision total knee arthroplasty. A prospective cohort study of one hundred and eighty-three knees. J Bone Joint Surg Am. 2009; 91(3): 628-633.

  23. Dall GF, Simpson PM, Breusch SJ: In vitro comparison of Refobacin-Palacos R with Refobacin Bone Cement and Palacos R+G. Acta Orthop. 2007; 78(3): 404-411.

  24. Greene N, Holtom PD, Warren CA, et al: In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from Simplex and Palacos. Am J Orthop (Belle Mead NJ). 1998; 27(3): 201-205.

  25. Meyer J, Piller G, Spiegel CA, Hetzel S, Squire M: Vacuum-mixing significantly changes antibiotic elution characteristics of commercially available antibiotic-impregnated bone cements. J Bone Joint Surg Am. 2011; 93(22): 2049-2056.

  26. Neut D, Kluin OS, Thompson J, van der Mei HC, Busscher HJ: Gentamicin release from commercially-available gentamicin-loaded PMMA bone cements in a prosthesis-related interfacial gap model and their antibacterial efficacy. BMC Musculoskelet Disord. 2011; 11: 258.

  27. Squire MW, Ludwig BJ, Thompson JR, Jagodzinski J, Hall D, Andes D: Premixed antibiotic bone cement: an in vitro comparison of antimicrobial efficacy. J Arthroplasty. 2008; 23(6 Suppl 1): 110-114.

  28. Stevens CM, Tetsworth KD, Calhoun JH, Mader JT: An articulated antibiotic spacer used for infected total knee arthroplasty: a comparative in vitro elution study of Simplex and Palacos bone cements. J Orthop Res. 2005; 23(1): 27-33.

  29. Cummins JS, Tomek IM, Kantor SR, Furnes O, Engesaeter LB, Finlayson SR: Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty. J Bone Joint Surg Am. 2009; 91(3): 634-641.

  30. Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ: Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplasty. 2010; 25(6 Suppl): 103-107.

  31. McLaren AC, Nugent M, Economopoulos K, Kaul H, Vernon BL, McLemore R: Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity. Clin Orthop Relat Res. 2009; 467(7): 1693-1698.

  32. Miller R, McLaren A, Leon C, McLemore R: Mixing method affects elution and strength of high-dose ALBC: a pilot study. Clin Orthop Relat Res. 2012; 470(10): 2677-2683.

  33. Song EK, Seon JK, Jeong MS: Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement. J Bone Joint Surg Br. 2010; 92(11): 1596-1599.

  34. Fink B, Vogt S, Reinsch M, Buchner H: Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res. 2011; 469(11): 3141-3147.

  35. Anguita-Alonso P, Rouse MS, Piper KE, Jacofsky DJ, Osmon DR, Patel R: Comparative study of antimicrobial release kinetics from polymethylmethacrylate. Clin Orthop Relat Res. 2006; 445: 239-244.

  36. Han CD, Oh T, Cho SN, Yang JH, Park KK: Isoniazid could be used for antibiotic-loaded bone cement for musculoskeletal tuberculosis: an in vitro study. Clin Orthop Relat Res. 2013; 471(7): 2400-2406.

  37. Adams K, Couch L, Cierny G, Calhoun J, Mader JT: In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop Relat Res. 1992(278): 244-252.

  38. Australian Orthopedic Association National Joint Replacement Registry [Internet]. [accessed July 14, 2013]. Available in: https://aoanjrr.dmac.adelaide.edu.au/en/annual-reports-2012.

  39. Milosev I, Kovac S, Trebse R, Levasic V, Pisot V: Comparison of ten-year survivorship of hip prostheses with use of conventional polyethylene, metal-on-metal, or ceramic-on-ceramic bearings. J Bone Joint Surg Am. 2012; 94(19): 1756-1763.

  40. Nikolaou VS, Edwards MR, Bogoch E, Schemitsch EH, Waddell JP: A prospective randomised controlled trial comparing three alternative bearing surfaces in primary total hip replacement. J Bone Joint Surg Br. 2012; 94(4): 459-465.

  41. Bozic KJ, Ong K, Lau E, et al: Risk of complication and revision total hip arthroplasty among Medicare patients with different bearing surfaces. Clin Orthop Relat Res. 2010; 468(9): 2357-2362.

  42. Bozic KJ, Lau EC, Ong KL, Vail TP, Rubash HE, Berry DJ: Comparative effectiveness of metal-on-metal and metal-on-polyethylene bearings in Medicare total hip arthroplasty patients. J Arthroplasty. 2012; 27(8 Suppl): 37-40.

  43. Pilge H, Gradl G, von Eisenhart-Rothe R, Gollwitzer H: Incidence and outcome after infection of megaprostheses. Hip Int. 2012; 22 Suppl 8: S83-90.

  44. Hardes J, Gebert C, Schwappach A, et al: Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg. 2006; 126(5): 289-296.

  45. Moojen DJ, Hentenaar B, Charles Vogely H, Verbout AJ, Castelein RM, Dhert WJ: In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. J Arthroplasty. 2008; 23(8): 1152-1156.

  46. Spierlings PT: Properties of bone cement: testing and performance of bone cements. In: Breusch S, Malchau H, eds. The Well-Cemented total hip arthroplasty: theory and practice. Heidelberg: Springer Medlizin Verlag Heidelberg; 2005: 67-78.

  47. Del Gaizo DJ, Kancherla V, Sporer SM, Paprosky WG: Tantalum augments for Paprosky IIIA defects remain stable at midterm followup. Clin Orthop Relat Res. 2012; 470(2): 395-401.

  48. Howard JL, Kudera J, Lewallen DG, Hanssen AD: Early results of the use of tantalum femoral cones for revision total knee arthroplasty. J Bone Joint Surg Am. 2011; 93(5): 478-484.

  49. Lachiewicz PF, Bolognesi MP, Henderson RA, Soileau ES, Vail TP: Can tantalum cones provide fixation in complex revision knee arthroplasty? Clin Orthop Relat Res. 2012; 470(1): 199-204.

  50. Sweet FA, Roh M, Sliva C: Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976). 2011; 36(24): 2084-2088.

  51. Villanueva-Martinez M, De la Torre-Escudero B, Rojo-Manaute JM, Rios-Luna A, Chana-Rodriguez F: Tantalum cones in revision total knee arthroplasty. A promising short-term result with 29 cones in 21 patients. J Arthroplasty. 2013; 28(6): 988-993.

  52. Molinari RW, Khera OA, Molinari WJ 3rd: Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period. Eur Spine J. 2012; 21 Suppl 4: S476-482.

  53. O’Neill KR, Smith JG, Abtahi AM, et al: Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder. Spine J. 2011; 11(7): 641-646.

  54. Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J: Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthop Relat Res. 2007; 461: 88-95.

  55. Parvizi J, Wickstrom E, Zeiger AR, et al: Frank Stinchfield Award. Titanium surface with biologic activity against infection. Clin Orthop Relat Res. 2004(429): 33-38.

  56. Stewart S, Barr S, Engiles J, et al: Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study. J Bone Joint Surg Am. 2012; 94(15): 1406-1415.

  57. Adams CS, Antoci V Jr, Harrison G, et al: Controlled release of vancomycin from thin sol-gel films on implant surfaces successfully controls osteomyelitis. J Orthop Res. 2009; 27(6): 701-709.

  58. Fiedler J, Kolitsch A, Kleffner B, Henke D, Stenger S, Brenner RE: Copper and silver ion implantation of aluminium oxide-blasted titanium surfaces: proliferative response of osteoblasts and antibacterial effects. Int J Artif Organs. 2011; 34(9): 882-888.

  59. Kose N, Otuzbir A, Peksen C, Kiremitci A, Dogan A: A Silver Ion-doped Calcium Phosphate-based Ceramic Nanopowder-coated Prosthesis Increased Infection Resistance. Clin Orthop Relat Res. 2013; 471(8): 2532-2539.

  60. Chai H, Guo L, Wang X, et al: Antibacterial effect of 317L stainless steel contained copper in prevention of implant-related infection in vitro and in vivo. J Mater Sci Mater Med. 2011; 22(11): 2525-2535.

  61. Heidenau F, Mittelmeier W, Detsch R, et al: A novel antibacterial titania coating: metal ion toxicity and in vitro surface colonization. J Mater Sci Mater Med. 2005; 16(10): 883-888.

  62. Haenle M, Fritsche A, Zietz C, et al: An extended spectrum bactericidal titanium dioxide (TiO2) coating for metallic implants: in vitro effectiveness against MRSA and mechanical properties. J Mater Sci Mater Med. 2011; 22(2): 381-387.

  63. Schaer TP, Stewart S, Hsu BB, Klibanov AM: Hydrophobic polycationic coatings that inhibit biofilms and support bone healing during infection. Biomaterials. 2012; 33(5): 1245-1254.

  64. Ellenrieder M, Haenle M, Lenz R, Bader R, Mittelmeier W: Titanium-copper-nitride coated spacers for two-stage revision of infected total hip endoprostheses. GMS Krankenhhyg Interdiszip. 2011; 6(1): Doc16.

  65. Hansen EN, Zmistowski B, Parvizi J: Periprosthetic joint infection: what is on the horizon? Int J Artif Organs. 2012; 35(10): 935-950.

  66. Ehrlich GD, Stoodley P, Kathju S, et al: Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin Orthop Relat Res. 2005(437): 59-66.

  67. Uhari M, Hietala J, Tuokko H: Risk of acute otitis media in relation to the viral etiology of infections in children. Clin Infect Dis. 1995; 20(3): 521-524.

  68. Radin S, Ducheyne P: Controlled release of vancomycin from thin sol-gel films on titanium alloy fracture plate material. Biomaterials. 2007; 28(9): 1721-1729.

  69. Wong SY, Moskowitz JS, Veselinovic J, et al: Dual functional polyelectrolyte multilayer coatings for implants: permanent microbicidal base with controlled release of therapeutic agents. J Am Chem Soc. 2012; 132(50): 17840-17848.

  70. Reddy ST, Chung KK, McDaniel CJ, Darouiche RO, Landman J, Brennan AB: Micropatterned surfaces for reducing the risk of catheter-associated urinary tract infection: an in vitro study on the effect of sharklet micropatterned surfaces to inhibit bacterial colonization and migration of uropathogenic Escherichia coli. J Endourol. 2012; 25(9): 1547-1552.




2020     |     www.medigraphic.com